HomeCompareGAUG vs JNJ

GAUG vs JNJ: Dividend Comparison 2026

GAUG yields 5.21% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GAUG wins by $8.1K in total portfolio value
10 years
GAUG
GAUG
● Live price
5.21%
Share price
$38.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$28.2K
Annual income
$726.33
Full GAUG calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — GAUG vs JNJ

📍 GAUG pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodGAUGJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, GAUG + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
GAUG pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GAUG
Annual income on $10K today (after 15% tax)
$442.59/yr
After 10yr DRIP, annual income (after tax)
$617.38/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $86.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GAUG + JNJ for your $10,000?

GAUG: 50%JNJ: 50%
100% JNJ50/50100% GAUG
Portfolio after 10yr
$24.1K
Annual income
$777.05/yr
Blended yield
3.23%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GAUG
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GAUG buys
0
JNJ buys
0
No recent congressional trades found for GAUG or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricGAUGJNJ
Forward yield5.21%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$28.2K$20.0K
Annual income after 10y$726.33$827.78
Total dividends collected$6.3K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: GAUG vs JNJ ($10,000, DRIP)

YearGAUG PortfolioGAUG Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,221$520.70$10,676$355.77+$545.00GAUG
2$12,552$546.04$11,407$389.39+$1.1KGAUG
3$14,002$570.87$12,198$426.53+$1.8KGAUG
4$15,577$595.13$13,056$467.62+$2.5KGAUG
5$17,286$618.78$13,987$513.12+$3.3KGAUG
6$19,138$641.75$14,998$563.56+$4.1KGAUG
7$21,142$664.01$16,098$619.52+$5.0KGAUG
8$23,307$685.55$17,295$681.69+$6.0KGAUG
9$25,645$706.32$18,599$750.82+$7.0KGAUG
10$28,166$726.33$20,022$827.78+$8.1KGAUG

GAUG vs JNJ: Complete Analysis 2026

GAUGStock

The investment objective of the FT Vest U.S. Equity Moderate Buffer ETF - August ("the Fund") is to seek to provide investors with returns (before fees and expenses) that match the price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to a predetermined upside cap of 11.89% while providing a buffer (before fees and expenses) against the first 15% of Underlying ETF losses, over the period from August 18, 2025 to August 21, 2026.

Full GAUG Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this GAUG vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GAUG vs SCHDGAUG vs JEPIGAUG vs OGAUG vs KOGAUG vs MAINGAUG vs ABBVGAUG vs MRKGAUG vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.